December 8, 2017
The Japanese government and the ruling Liberal Democratic Party on December 7 agreed on a modification to new requirements proposed for the so-called price maintenance premium (PMP) for on-patent drugs after the research-driven pharmaceutical industry railed against the original plan...read more